AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT by and between NOVAVAX, INC. and KING PHARMACEUTICALS, INC. Dated as of June 26, 2002Investor Rights Agreement • July 2nd, 2002 • Novavax Inc • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledJuly 2nd, 2002 Company Industry JurisdictionTHIS AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (this “Agreement”) is made as of the 26th day of June, 2002 by and between NOVAVAX, INC., a Delaware corporation (the “Company”), and KING PHARMACEUTICALS, INC., a Tennessee corporation (“King”).
JUNE 2002 NOTE PURCHASE AGREEMENT by and between NOVAVAX, INC. and KING PHARMACEUTICALS, INC. Dated as of June 26, 2002June 2002 Note Purchase Agreement • July 2nd, 2002 • Novavax Inc • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledJuly 2nd, 2002 Company Industry Jurisdiction
THIRD AMENDMENT TO THE COPROMOTION AGREEMENTThe Copromotion Agreement • July 2nd, 2002 • Novavax Inc • Biological products, (no disgnostic substances)
Contract Type FiledJuly 2nd, 2002 Company IndustryTHIS THIRD AMENDMENT TO THE COPROMOTION AGREEMENT (this “Third Amendment”) is entered into as of June 26, 2002, by and between KING PHARMACEUTICALS, INC., a Tennessee corporation (“King”), and NOVAVAX, INC., a Delaware corporation (hereinafter, “Novavax”).